Quels risques psychologiques liés à l'exposition ?
L'exposition peut entraîner des troubles anxieux, dépressifs ou des stress post-traumatiques.
Troubles psychologiquesStress post-traumatique
Facteurs de risque
5
#1
Quels facteurs augmentent le risque d'intoxication ?
Les facteurs incluent l'âge, l'état de santé, et l'exposition professionnelle fréquente.
Facteurs de risqueIntoxication
#2
Comment l'environnement influence-t-il le risque ?
La pollution, la proximité des sites industriels et les conditions de travail augmentent le risque.
EnvironnementPollution
#3
Quels comportements à risque ?
Le non-port d'EPI, la consommation d'alcool et le non-respect des protocoles de sécurité sont risqués.
Comportements à risqueÉquipements de protection individuelle
#4
Quel rôle joue la formation dans la prévention ?
Une formation adéquate réduit les risques d'accidents et améliore la gestion des urgences.
FormationPrévention des accidents
#5
Comment les antécédents médicaux influencent-ils le risque ?
Les antécédents de maladies respiratoires ou dermatologiques augmentent le risque d'effets néfastes.
Antécédents médicauxMaladies respiratoires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Fiches techniques sur la sécurité des substances : Questions médicales les plus fréquentes",
"headline": "Fiches techniques sur la sécurité des substances : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Fiches techniques sur la sécurité des substances : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-30",
"dateModified": "2025-03-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Fiches techniques sur la sécurité des substances"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Gestion de la sécurité",
"url": "https://questionsmedicales.fr/mesh/D017751",
"about": {
"@type": "MedicalCondition",
"name": "Gestion de la sécurité",
"code": {
"@type": "MedicalCode",
"code": "D017751",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.135.060.075.800"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Fiches techniques sur la sécurité des substances",
"alternateName": "Material Safety Data Sheets",
"code": {
"@type": "MedicalCode",
"code": "D063967",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "So Mi Jemma Cho",
"url": "https://questionsmedicales.fr/author/So%20Mi%20Jemma%20Cho",
"affiliation": {
"@type": "Organization",
"name": "Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea."
}
},
{
"@type": "Person",
"name": "Hokyou Lee",
"url": "https://questionsmedicales.fr/author/Hokyou%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea."
}
},
{
"@type": "Person",
"name": "Jongmin Baek",
"url": "https://questionsmedicales.fr/author/Jongmin%20Baek",
"affiliation": {
"@type": "Organization",
"name": "Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea."
}
},
{
"@type": "Person",
"name": "Hyeon Chang Kim",
"url": "https://questionsmedicales.fr/author/Hyeon%20Chang%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea."
}
},
{
"@type": "Person",
"name": "Lisa-Maria Wittmann",
"url": "https://questionsmedicales.fr/author/Lisa-Maria%20Wittmann",
"affiliation": {
"@type": "Organization",
"name": "Department of Mechanical Engineering, Institute of Polymer Technology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Am Weichselgarten 10, 91058 Erlangen, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma.",
"datePublished": "2022-09-09",
"url": "https://questionsmedicales.fr/article/36085204",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10067-022-06364-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma Patients.",
"datePublished": "2023-02-01",
"url": "https://questionsmedicales.fr/article/36281773",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/art.42380"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Case of Diffuse Scleroderma Presenting as Hypertensive Encephalopathy Due to Scleroderma Renal Crisis.",
"datePublished": "2024-06-05",
"url": "https://questionsmedicales.fr/article/38975413",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.61732"
}
},
{
"@type": "ScholarlyArticle",
"name": "Interleukin-36α is elevated in diffuse systemic sclerosis and may potentiate fibrosis.",
"datePublished": "2022-06-03",
"url": "https://questionsmedicales.fr/article/35667282",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cyto.2022.155921"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Novel Cytokine Interleukin-41/Meteorin-like Is Reduced in Diffuse Systemic Sclerosis.",
"datePublished": "2024-07-17",
"url": "https://questionsmedicales.fr/article/39056787",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cells13141205"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Accidents",
"item": "https://questionsmedicales.fr/mesh/D000059"
},
{
"@type": "ListItem",
"position": 5,
"name": "Prévention des accidents",
"item": "https://questionsmedicales.fr/mesh/D000056"
},
{
"@type": "ListItem",
"position": 6,
"name": "Sécurité",
"item": "https://questionsmedicales.fr/mesh/D012449"
},
{
"@type": "ListItem",
"position": 7,
"name": "Gestion de la sécurité",
"item": "https://questionsmedicales.fr/mesh/D017751"
},
{
"@type": "ListItem",
"position": 8,
"name": "Fiches techniques sur la sécurité des substances",
"item": "https://questionsmedicales.fr/mesh/D063967"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Fiches techniques sur la sécurité des substances - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Fiches techniques sur la sécurité des substances",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Fiches techniques sur la sécurité des substances",
"description": "Comment identifier une substance dangereuse ?\nQuels tests pour évaluer la toxicité d'une substance ?\nComment évaluer l'exposition à une substance ?\nQuels indicateurs de dangerosité ?\nComment reconnaître une intoxication ?",
"url": "https://questionsmedicales.fr/mesh/D063967?mesh_terms=Scleroderma,+Diffuse#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Fiches techniques sur la sécurité des substances",
"description": "Quels symptômes d'une exposition chimique ?\nComment se manifeste une intoxication aiguë ?\nQuels signes d'allergie à une substance ?\nQuels symptômes d'une exposition prolongée ?\nComment reconnaître une brûlure chimique ?",
"url": "https://questionsmedicales.fr/mesh/D063967?mesh_terms=Scleroderma,+Diffuse#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Fiches techniques sur la sécurité des substances",
"description": "Comment prévenir les accidents chimiques ?\nQuelles mesures de sécurité en laboratoire ?\nComment stocker les substances dangereuses ?\nQuelles formations pour le personnel ?\nComment gérer les déchets chimiques ?",
"url": "https://questionsmedicales.fr/mesh/D063967?mesh_terms=Scleroderma,+Diffuse#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Fiches techniques sur la sécurité des substances",
"description": "Quel traitement pour une intoxication ?\nComment traiter une brûlure chimique ?\nQuels soins pour une irritation cutanée ?\nComment gérer une exposition par inhalation ?\nQuel suivi après exposition à une substance ?",
"url": "https://questionsmedicales.fr/mesh/D063967?mesh_terms=Scleroderma,+Diffuse#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Fiches techniques sur la sécurité des substances",
"description": "Quelles complications d'une exposition chimique ?\nQuels effets à long terme d'une intoxication ?\nComment les substances affectent-elles la reproduction ?\nQuelles maladies liées à l'exposition professionnelle ?\nQuels risques psychologiques liés à l'exposition ?",
"url": "https://questionsmedicales.fr/mesh/D063967?mesh_terms=Scleroderma,+Diffuse#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Fiches techniques sur la sécurité des substances",
"description": "Quels facteurs augmentent le risque d'intoxication ?\nComment l'environnement influence-t-il le risque ?\nQuels comportements à risque ?\nQuel rôle joue la formation dans la prévention ?\nComment les antécédents médicaux influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D063967?mesh_terms=Scleroderma,+Diffuse#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier une substance dangereuse ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vérifiez les étiquettes, les fiches de données de sécurité et les pictogrammes de danger."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer la toxicité d'une substance ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests in vitro et in vivo, ainsi que des études épidémiologiques, sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'exposition à une substance ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisez des méthodes de surveillance environnementale et des questionnaires d'exposition."
}
},
{
"@type": "Question",
"name": "Quels indicateurs de dangerosité ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les indicateurs incluent la toxicité aiguë, la corrosivité et la réactivité."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une intoxication ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveillez les symptômes cliniques et les antécédents d'exposition à la substance."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une exposition chimique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des nausées, des vertiges, des irritations cutanées."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une intoxication aiguë ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut se manifester par des troubles respiratoires, des convulsions ou un coma."
}
},
{
"@type": "Question",
"name": "Quels signes d'allergie à une substance ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des éruptions cutanées, des démangeaisons et des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une exposition prolongée ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes chroniques peuvent inclure des troubles neurologiques et des cancers."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une brûlure chimique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les brûlures chimiques se manifestent par des rougeurs, des cloques et des douleurs."
}
},
{
"@type": "Question",
"name": "Comment prévenir les accidents chimiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Formez le personnel, utilisez des équipements de protection et suivez les protocoles de sécurité."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité en laboratoire ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisez des hottes, portez des gants et des lunettes de protection, et suivez les procédures."
}
},
{
"@type": "Question",
"name": "Comment stocker les substances dangereuses ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Stockez-les dans des contenants appropriés, étiquetés et dans des zones ventilées."
}
},
{
"@type": "Question",
"name": "Quelles formations pour le personnel ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Formez le personnel sur les risques, les procédures d'urgence et l'utilisation des EPI."
}
},
{
"@type": "Question",
"name": "Comment gérer les déchets chimiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivez les réglementations locales pour le tri, le stockage et l'élimination des déchets."
}
},
{
"@type": "Question",
"name": "Quel traitement pour une intoxication ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la substance, mais peut inclure des antidotes et des soins de soutien."
}
},
{
"@type": "Question",
"name": "Comment traiter une brûlure chimique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rincez immédiatement la zone touchée à l'eau et consultez un professionnel de santé."
}
},
{
"@type": "Question",
"name": "Quels soins pour une irritation cutanée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Nettoyez la zone affectée et appliquez des crèmes apaisantes ou des antihistaminiques."
}
},
{
"@type": "Question",
"name": "Comment gérer une exposition par inhalation ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éloignez la personne de la source, administrez de l'oxygène et surveillez les signes vitaux."
}
},
{
"@type": "Question",
"name": "Quel suivi après exposition à une substance ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical est essentiel pour détecter d'éventuels effets à long terme."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une exposition chimique ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des maladies respiratoires chroniques et des cancers."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme d'une intoxication ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets neurologiques, hépatiques ou rénaux peuvent survenir après une intoxication."
}
},
{
"@type": "Question",
"name": "Comment les substances affectent-elles la reproduction ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines substances peuvent causer des malformations congénitales ou des infertilités."
}
},
{
"@type": "Question",
"name": "Quelles maladies liées à l'exposition professionnelle ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maladies comme l'asthme, la dermatite et des cancers peuvent être liées à l'exposition."
}
},
{
"@type": "Question",
"name": "Quels risques psychologiques liés à l'exposition ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition peut entraîner des troubles anxieux, dépressifs ou des stress post-traumatiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'intoxication ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, l'état de santé, et l'exposition professionnelle fréquente."
}
},
{
"@type": "Question",
"name": "Comment l'environnement influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pollution, la proximité des sites industriels et les conditions de travail augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels comportements à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le non-port d'EPI, la consommation d'alcool et le non-respect des protocoles de sécurité sont risqués."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la formation dans la prévention ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une formation adéquate réduit les risques d'accidents et améliore la gestion des urgences."
}
},
{
"@type": "Question",
"name": "Comment les antécédents médicaux influencent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de maladies respiratoires ou dermatologiques augmentent le risque d'effets néfastes."
}
}
]
}
]
}
Department of Mechanical Engineering, Institute of Polymer Technology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Am Weichselgarten 10, 91058 Erlangen, Germany.
Publications dans "Fiches techniques sur la sécurité des substances" :
Department of Mechanical Engineering, Institute of Polymer Technology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Am Weichselgarten 10, 91058 Erlangen, Germany.
Publications dans "Fiches techniques sur la sécurité des substances" :
Centre for Occupational and Environmental Health, School of Health Sciences, University of Manchester, 4th Floor, Ellen Wilkinson Building, Oxford Road, Manchester, M13 9PL, UK.
Publications dans "Fiches techniques sur la sécurité des substances" :
Centre for Occupational and Environmental Health, School of Health Sciences, University of Manchester, 4th Floor, Ellen Wilkinson Building, Oxford Road, Manchester, M13 9PL, UK.
Publications dans "Fiches techniques sur la sécurité des substances" :
Department of Environmental Health, Institute of Health and Environment, Graduate School of Public Health, Seoul National University, Republic of Korea.
Publications dans "Fiches techniques sur la sécurité des substances" :
Department of Environmental Health, Institute of Health and Environment, Graduate School of Public Health, Seoul National University, Republic of Korea.
Publications dans "Fiches techniques sur la sécurité des substances" :
Department of Environmental Health, Institute of Health and Environment, Graduate School of Public Health, Seoul National University, Republic of Korea.
Publications dans "Fiches techniques sur la sécurité des substances" :
Scleroderma is a rare complication in taxanes therapy. Although individual cases of taxanes-induced scleroderma have been reported, the clinical manifestation and treatment outcomes were reviewed and ...
A PubMed literature review on published cases of taxanes-induced scleroderma up until April 2022 was included for analysis....
The search identified 27 patients with adequate information for analysis. Of the 28 patients, including the one presented here, 22 were female. Peripheral edema was the most common symptom in all but ...
Taxanes-induced scleroderma is different from idiopathic scleroderma. Physicians should be aware of this condition in order to provide early diagnosis and apply appropriate management in order to avoi...
Patients with diffuse cutaneous systemic sclerosis (dcSSc) display a complex clinical phenotype. Transcriptional profiling of whole blood or tissue from patients are affected by changes in cellular co...
SSc patients were recruited from the Prospective Registry for Early Systemic Sclerosis. Clinical data were collected, as well as peripheral blood for isolation of CMs and NCMs. Age-, sex-, and race-ma...
We used an unbiased approach to cluster patients into 3 groups (groups A-C) based on the transcriptional signatures of CMs relative to controls. Each group maintained their characteristic transcriptio...
We are the first to show that transcriptional signatures of CMs and NCMs can be used to unbiasedly stratify SSc patients and correlate with disease activity outcome measures....
This case report details a rare presentation of diffuse scleroderma, where a 38-year-old female developed hypertensive encephalopathy due to scleroderma renal crisis (SRC). SRC, characterized by sudde...
Systemic sclerosis (SSc) is an autoimmune prototypical connective tissues disease that results in alterations in vasculature, inflammation and fibrosis of the skin. Interleukin-1 family cytokines has ...
Systemic sclerosis (SSc) is an autoimmune connective tissue disease with a triad of features that include vascular abnormalities, inflammation and skin and lung fibrosis. At the core of the disease is...
Diffuse cutaneous systemic sclerosis (SSc) is a highly heterogeneous disease. A provisionally approved Composite Response Index in diffuse cutaneous SSc (CRISS) was developed as a 1-year outcome measu...
Patient profiles from a large observational cohort were created for 50 random diffuse cutaneous SSc patients of <5 years disease duration with improved CRISS scores after 1 year and 50 with non-improv...
Patients had mean ± SD disease duration of 2.2 ± 1.3 years. There was substantial agreement between the physician majority opinion about each case and the CRISS (κ = 0.76 [95% confidence interval (95%...
There was substantial agreement between the dichotomous CRISS rating and physician assessment of diffuse cutaneous SSc patients after 1 year. This supports the use of a CRISS cutoff at 0.6 for improve...
Systemic sclerosis, an autoimmune disease characterized by fibrosis and vasculopathy of the skin and other multiple organs has been associated with an increased risk of malignancy. We present the case...
To evaluate the baseline clinical characteristics of juvenile systemic sclerosis (SSc) patients in the international juvenile SSc inception cohort, and to compare these characteristics between the cla...
A cross-sectional study was performed using baseline visit data. Information on demographic characteristics, organ system evaluation, treatment, and patient- and physician-reported outcomes was extrac...
At data extraction, 150 juvenile SSc patients were enrolled across 42 centers; 83% were White, 80% were female, juvenile dcSSc predominated (72%), and 17% of the cohort had overlap features. Significa...
Results from a large international juvenile SSc cohort demonstrate significant differences between juvenile dcSSc and juvenile lcSSc patients, including more globally severe disease and increased freq...
Scleroderma or systemic sclerosis (SSc) is an autoimmune disease affecting the connective tissue, characterized by fibrosis of the skin and internal organs. There is currently no curative treatment av...
Scleroderma is a complex autoimmune disorder that primarily affects the connective tissue. Its key pathogenesis comprises vascular abnormalities, autoimmunity, and tissue fibrosis. While the exact eti...